Citigroup Maintains Buy on Johnson & Johnson, Raises Price Target to $185

Benzinga · 10/16 19:11
Citigroup analyst Joanne Wuensch maintains Johnson & Johnson (NYSE:JNJ) with a Buy and raises the price target from $180 to $185.